| Literature DB >> 10202115 |
G Cutrona1, N Leanza, M Ulivi, M B Majolini, G Taborelli, S Zupo, C T Baldari, S Roncella, M Ferrarini.
Abstract
Using immunofluorescence, RT-PCR, and Western blotting, we have demonstrated the ability of human B cells to express CD4. In each of the 10 lymphoblastoid cell lines (LCL) tested there was variable, but definite, proportion of CD4-positive B cells. Expression of CD4 was related to the cell cycle; CD4 was expressed in the G1 phase and continued at later phases of the cell cycle. CD4 was in part internalized and degraded by the LCL B cells. Surface CD4 was associated to lck and its crosslinking resulted in tyrosine phosphorylation. Additional experiments conducted on freshly prepared tonsillar B cells demonstrated that CD4 was expressed by large activated B cells, but not by small resting B cells. However, not all the activated tonsillar B cells had surface CD4 since germinal center cells were CD4-negative. Crosslinking of CD4 on LCL or on tonsillar activated B cells resulted in apoptosis in vitro, a finding that indicates the capacity of CD4 to deliver functional signals to B cells and to play a regulatory function in their physiology. Exposure of CD4 expressing B cells to gp120 under conditions that resulted in CD4 crosslinking also caused apoptosis suggesting some implications for the pathophysiology of AIDS. Copyright 1999 Academic Press.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10202115 DOI: 10.1006/cimm.1999.1455
Source DB: PubMed Journal: Cell Immunol ISSN: 0008-8749 Impact factor: 4.868